University of Pittsburgh

University of Pittsburgh

group_PittContact Information

  University of Pittsburgh
3471 Fifth Avenue, Suite 811
Pittsburgh, Pennsylvania 15213

  Larry Ivanco (412) 692-2394

lsi1@pitt.edu


Trials/Studies

pride300x792care300x79crest300x79

Site Coordinator


unpictured_man_green
Larry Ivanco, MSW, BSc
unpictured_woman_orange
Patricia Conlon, BS

Site Investigators

Greenamyre_PittTimothy John Greenamyre, MD, PhD

J. Timothy Greenamyre, MD, PhD, is professor of neurology, UPMC endowed chair & chief of Movement Disorders, and director of the Pittsburgh Institute for Neurodegenerative Diseases (PIND) and the American Parkinson Disease Association Advanced Center for Parkinson’s Disease Research at the University of Pittsburgh. He is a member of the scientific advisory board of the Michael J. Fox Foundation, and a member of the scientific advisory committees of the Cure Parkinson’s Project, and the Parkinson’s Disease Foundation.

In Huntington’s disease, his lab focuses on mitochondrial calcium handling and proteomics. The general strategy is to define mechanisms that cause nerve cell death, and then use them as potential ”targets” for therapeutic intervention. The lab employs in vivo models of neurodegeneration and in vitro culture of cells and brain slices to study mechanisms of degeneration with a variety of biochemical, anatomical and physiological techniques.

 

Suski_pittValerie Suski, DO

Dr. Suski is an active member of the Comprehensive Movement Disorders Clinic/Pittsburgh Institute of Neurodegenerative Diseases providing evaluation and treatments including botulinum toxin and deep brain stimulator programming to patients with a wide variety of movement disorders. She became the new director of the UPMC Huntington’s Disease Clinic in July 2009. This is a multidisciplinary clinic consisting of physicians, social workers, genetic counselors, and clinical trial coordinators that provides care for both patients with Huntington’s disease and their families. She is a member of the Huntington’s Study Group and is currently participating in several Huntington’s disease clinical trials.

Dr. Suski provides the services of the Movement Disorders Clinic through Telemedicine once a month to a remote community location where this subspeciality is needed. She is especially interested in non-motor complications in Parkinson’s disease, atypical Parkinsonism, dystonia, tremor and Huntington’s disease. Dr. Suski remains extremely active in service to the Parkinson Support Group community in the Western Pennsylvania region.